Cargando…

A Clinical, Etiological, and Therapeutic Profile of Gynecomastia

Background and objective Gynecomastia is defined as a benign proliferation of male breast glandular tissue, either unilateral or bilateral, resulting from an imbalance of testosterone and estrogen. In this study, we aimed to describe the clinical, etiological, and therapeutic aspects of gynecomastia...

Descripción completa

Detalles Bibliográficos
Autores principales: Elazizi, Lamiaa, Essafi, Mohammed Amine, Hanane, Aabi, Aynaou, Hayat, Salhi, Houda, El Ouahabi, Hanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440797/
https://www.ncbi.nlm.nih.gov/pubmed/36072183
http://dx.doi.org/10.7759/cureus.27687
_version_ 1784782433632124928
author Elazizi, Lamiaa
Essafi, Mohammed Amine
Hanane, Aabi
Aynaou, Hayat
Salhi, Houda
El Ouahabi, Hanan
author_facet Elazizi, Lamiaa
Essafi, Mohammed Amine
Hanane, Aabi
Aynaou, Hayat
Salhi, Houda
El Ouahabi, Hanan
author_sort Elazizi, Lamiaa
collection PubMed
description Background and objective Gynecomastia is defined as a benign proliferation of male breast glandular tissue, either unilateral or bilateral, resulting from an imbalance of testosterone and estrogen. In this study, we aimed to describe the clinical, etiological, and therapeutic aspects of gynecomastia. Materials and methods A retrospective, descriptive study was conducted in the Department of Endocrinology, Diabetology, and Nutrition at the Hassan II University Hospital in Fez, Morocco, over a period of 10 years. We included all patients admitted for exploration and treatment of gynecomastia. The data were analyzed using Microsoft Excel 2016 and SPSS Statistics version 18 (IBM, Armonk, NY). Results A total of 86 patients were included in this study; the mean age of the patients was 33 years (range: 15-86 years). A family history of gynecomastia was found in 4.6%. Isolated gynecomastia was the most frequent symptom (60.4% of cases). It was bilateral in 54% of cases, stage II in 63% of patients, stage I in 17%, and stage III in 20%. The first-line assessment (renal insufficiency, hepatic insufficiency/cirrhosis, dysthyroidism) was normal in the majority of cases. The etiologies were dominated by hypogonadism in 32.6% of cases, pubertal gynecomastia in 21%, and senile gynecomastia in 8.1%. Regarding treatment, 42% of patients received an etiological treatment, while surgical treatment was provided in 28% of cases, observation in 15% of cases, and androgen therapy in 15%. Pathological examination of all surgical specimens was benign. The follow-up was marked by 30.3% of static gynecomastia, 29% of regression, 17.5% of good response after surgery, and 24.4% of treatment refusal. Conclusions It is important to adopt a step-by-step approach in treating gynecomastia, starting with detailed questioning and clinical examination. The surgical treatment is currently the treatment of choice, the final goal of which is good aesthetic as well as psychological outcomes.
format Online
Article
Text
id pubmed-9440797
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-94407972022-09-06 A Clinical, Etiological, and Therapeutic Profile of Gynecomastia Elazizi, Lamiaa Essafi, Mohammed Amine Hanane, Aabi Aynaou, Hayat Salhi, Houda El Ouahabi, Hanan Cureus Endocrinology/Diabetes/Metabolism Background and objective Gynecomastia is defined as a benign proliferation of male breast glandular tissue, either unilateral or bilateral, resulting from an imbalance of testosterone and estrogen. In this study, we aimed to describe the clinical, etiological, and therapeutic aspects of gynecomastia. Materials and methods A retrospective, descriptive study was conducted in the Department of Endocrinology, Diabetology, and Nutrition at the Hassan II University Hospital in Fez, Morocco, over a period of 10 years. We included all patients admitted for exploration and treatment of gynecomastia. The data were analyzed using Microsoft Excel 2016 and SPSS Statistics version 18 (IBM, Armonk, NY). Results A total of 86 patients were included in this study; the mean age of the patients was 33 years (range: 15-86 years). A family history of gynecomastia was found in 4.6%. Isolated gynecomastia was the most frequent symptom (60.4% of cases). It was bilateral in 54% of cases, stage II in 63% of patients, stage I in 17%, and stage III in 20%. The first-line assessment (renal insufficiency, hepatic insufficiency/cirrhosis, dysthyroidism) was normal in the majority of cases. The etiologies were dominated by hypogonadism in 32.6% of cases, pubertal gynecomastia in 21%, and senile gynecomastia in 8.1%. Regarding treatment, 42% of patients received an etiological treatment, while surgical treatment was provided in 28% of cases, observation in 15% of cases, and androgen therapy in 15%. Pathological examination of all surgical specimens was benign. The follow-up was marked by 30.3% of static gynecomastia, 29% of regression, 17.5% of good response after surgery, and 24.4% of treatment refusal. Conclusions It is important to adopt a step-by-step approach in treating gynecomastia, starting with detailed questioning and clinical examination. The surgical treatment is currently the treatment of choice, the final goal of which is good aesthetic as well as psychological outcomes. Cureus 2022-08-04 /pmc/articles/PMC9440797/ /pubmed/36072183 http://dx.doi.org/10.7759/cureus.27687 Text en Copyright © 2022, Elazizi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Elazizi, Lamiaa
Essafi, Mohammed Amine
Hanane, Aabi
Aynaou, Hayat
Salhi, Houda
El Ouahabi, Hanan
A Clinical, Etiological, and Therapeutic Profile of Gynecomastia
title A Clinical, Etiological, and Therapeutic Profile of Gynecomastia
title_full A Clinical, Etiological, and Therapeutic Profile of Gynecomastia
title_fullStr A Clinical, Etiological, and Therapeutic Profile of Gynecomastia
title_full_unstemmed A Clinical, Etiological, and Therapeutic Profile of Gynecomastia
title_short A Clinical, Etiological, and Therapeutic Profile of Gynecomastia
title_sort clinical, etiological, and therapeutic profile of gynecomastia
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440797/
https://www.ncbi.nlm.nih.gov/pubmed/36072183
http://dx.doi.org/10.7759/cureus.27687
work_keys_str_mv AT elazizilamiaa aclinicaletiologicalandtherapeuticprofileofgynecomastia
AT essafimohammedamine aclinicaletiologicalandtherapeuticprofileofgynecomastia
AT hananeaabi aclinicaletiologicalandtherapeuticprofileofgynecomastia
AT aynaouhayat aclinicaletiologicalandtherapeuticprofileofgynecomastia
AT salhihouda aclinicaletiologicalandtherapeuticprofileofgynecomastia
AT elouahabihanan aclinicaletiologicalandtherapeuticprofileofgynecomastia
AT elazizilamiaa clinicaletiologicalandtherapeuticprofileofgynecomastia
AT essafimohammedamine clinicaletiologicalandtherapeuticprofileofgynecomastia
AT hananeaabi clinicaletiologicalandtherapeuticprofileofgynecomastia
AT aynaouhayat clinicaletiologicalandtherapeuticprofileofgynecomastia
AT salhihouda clinicaletiologicalandtherapeuticprofileofgynecomastia
AT elouahabihanan clinicaletiologicalandtherapeuticprofileofgynecomastia